|
Learning Objectives
1. Name the therapeutic class for each new agent.
2. Describe the disease state for which each new agent is indicated.
3. Discuss the dosage form and route of administration for each new agent.
4. Describe the most serious adverse effect for each class of agent discussed.
5. List special considerations related to storage, preparation, and dispensing for each new agent.
Meet the author
Anna Nowobilski-Vasilios, Pharm.D., MBA, FASHP, CNSC, BCNSP is Principal at Anovation, Inc., a firm specializing in the consultative support of home infusion, specialty pharmacy, ambulatory care, and other industries related to outpatient clinical services. Prior to establishing her consulting practice, she served Option Care for 14 years in roles of increasing responsibility, culminating as Senior Vice President of Care Management Services. Previously, she held various management and clinical positions at home infusion companies, home health agencies, and hospitals. She received her BS (Pharmacy) from the University of Illinois, MBA from the Keller Graduate School, and PharmD from Midwestern University. She is board certified in nutrition support (CNSC) and
nutrition support pharmacy (BCNSP), and a Fellow of the American Society of Health-System Pharmacists (FASHP). She is an active member of ASHP, NHIA, ASPEN, INS, ICHP, and the Polish American Pharmacists’ Association and adjunct pharmacy practice faculty at Midwestern University, Chicago State University, and the University of Illinois. She has spoken and published on topics related to home infusion therapy, specialty pharmacy, new drug approvals, sterile preparation, nutrition support, and interdisciplinary collaboration.
This module will provide 2.5 contact hours of continuing pharmacy education credit for pharmacy technicians.
ACPE UAN: 0121-0000-15-004-H01-T | Activity Type: Knowledge-based
Release date: October 1, 2015 | Expiration date: October 31, 2017 |